Article info
PDFOriginal article
Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer
- Correspondence to Professor Hans Morreau, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands; j.morreau{at}lumc.nl
Citation
Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer
Publication history
- Received June 7, 2017
- Revised July 7, 2017
- Accepted July 7, 2017
- First published August 3, 2017.
Online issue publication
July 01, 2020
Article Versions
- Previous version (15 June 2020).
- Previous version (15 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.